Founded in 2008, CellMosaic® has been a pioneer in bioconjugation, delivering high-quality solutions powered by proprietary AqueaTether® (AqT®) technologies and advanced bioconjugation processes to advance next-generation bioconjugates and targeted therapeutics.
Learn More →